Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erica L Carpenter

Showing results (41-50 of 87) with videos related to

Pageof 9
Sort By:
Nature Genetics|September 4, 2012
Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastomaSharon J Diskin, Mario Capasso, Robert W Schnepp, et al.
Scientific Reports|May 12, 2021
Combining radiomic phenotypes of non-small cell lung cancer with liquid biopsy data may improve prediction of response to EGFR inhibitorsBardia Yousefi, Michael J LaRiviere, Eric A Cohen, et al.
Breast Cancer Research : BCR|May 22, 2025
miRNA panel from HER2+ and CD24+ plasma extracellular vesicle subpopulations as biomarkers of early-stage breast cancerGriffin B Spychalski, Andrew A Lin, Stephanie J Yang, et al.
Neuro-Oncology Advances|February 22, 2021
Association of plasma cell-free DNA with survival in patients with IDH wild-type glioblastomaStephen J Bagley, Jacob Till, Aseel Abdalla, et al.
JCO Precision Oncology|February 16, 2019
Influence of <i>TP53</i> Mutation on Survival in Patients With Advanced <i>EGFR</i>-Mutant Non-Small-Cell Lung CancerCharu Aggarwal, Christiana W Davis, Rosemarie Mick, et al.
Scientific Reports|June 15, 2022
Development of a robust radiomic biomarker of progression-free survival in advanced non-small cell lung cancer patients treated with first-line immunotherapyApurva Singh, Hannah Horng, Leonid Roshkovan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2009
Collapse of the CD27+ B-cell compartment associated with systemic plasmacytosis in patients with advanced melanoma and other cancersErica L Carpenter, Rosemarie Mick, Andrew J Rech, et al.
Cancer|June 14, 2025
A phase 1 dual-dose escalation study of radiation and nab-paclitaxel in patients with unresectable and borderline resectable pancreatic cancerUri Amit, James M Metz, John P Plastaras, et al.
Clinical and Translational Medicine|July 11, 2022
Transcriptional profiling of single tumour cells from pleural effusions reveals heterogeneity of epithelial to mesenchymal transition and extra-cellular matrix marker expressionMoen Sen, Ryan M Hausler, Keely Dulmage, et al.
Cancer Research|November 3, 2007
Telomerase-specific T-cell immunity in breast cancer: effect of vaccination on tumor immunosurveillanceSusan M Domchek, Adri Recio, Rosemarie Mick, et al.
Pageof 9

Showing results (41-50 of 87) with videos related to

Sort By:
Pageof 9
Nature Genetics|September 4, 2012
Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastomaSharon J Diskin, Mario Capasso, Robert W Schnepp, et al.
Scientific Reports|May 12, 2021
Combining radiomic phenotypes of non-small cell lung cancer with liquid biopsy data may improve prediction of response to EGFR inhibitorsBardia Yousefi, Michael J LaRiviere, Eric A Cohen, et al.
Breast Cancer Research : BCR|May 22, 2025
miRNA panel from HER2+ and CD24+ plasma extracellular vesicle subpopulations as biomarkers of early-stage breast cancerGriffin B Spychalski, Andrew A Lin, Stephanie J Yang, et al.
Neuro-Oncology Advances|February 22, 2021
Association of plasma cell-free DNA with survival in patients with IDH wild-type glioblastomaStephen J Bagley, Jacob Till, Aseel Abdalla, et al.
JCO Precision Oncology|February 16, 2019
Influence of <i>TP53</i> Mutation on Survival in Patients With Advanced <i>EGFR</i>-Mutant Non-Small-Cell Lung CancerCharu Aggarwal, Christiana W Davis, Rosemarie Mick, et al.
Scientific Reports|June 15, 2022
Development of a robust radiomic biomarker of progression-free survival in advanced non-small cell lung cancer patients treated with first-line immunotherapyApurva Singh, Hannah Horng, Leonid Roshkovan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2009
Collapse of the CD27+ B-cell compartment associated with systemic plasmacytosis in patients with advanced melanoma and other cancersErica L Carpenter, Rosemarie Mick, Andrew J Rech, et al.
Cancer|June 14, 2025
A phase 1 dual-dose escalation study of radiation and nab-paclitaxel in patients with unresectable and borderline resectable pancreatic cancerUri Amit, James M Metz, John P Plastaras, et al.
Clinical and Translational Medicine|July 11, 2022
Transcriptional profiling of single tumour cells from pleural effusions reveals heterogeneity of epithelial to mesenchymal transition and extra-cellular matrix marker expressionMoen Sen, Ryan M Hausler, Keely Dulmage, et al.
Cancer Research|November 3, 2007
Telomerase-specific T-cell immunity in breast cancer: effect of vaccination on tumor immunosurveillanceSusan M Domchek, Adri Recio, Rosemarie Mick, et al.
Pageof 9